News & Analysis on Clinical Trial Services & Contract Research And Development
IntelliChem, a developer of electronic laboratory notebooks (ELN) for the drug discovery and development industry, has launched a new ELN platform that can be used right across any pharmaceutical or biotechnology company.
A booster dose of a growth factor naturally present in the body appears to be safe and non-toxic for the treatment of pancreatic cancer, and shows signs of arresting pancreatic cancer cell growth in patients, according to researchers in the US.
A new screening approach which can identify a new drug mechanism of action without the need for an appropriate molecular target has been used to suppress genetic mutation. The discovery raises new hopes of identifying potential new drugs, harnessing...
UK-based analysis specialist LGC has signed two agreements with Poland's Institute of Industrial Organic Chemistry (IPO), highlighting the company's strategy of establishing partnerships to develop outside its home market.
The Netherlands-based pharmaceuticals, coatings and chemicals firm Akzo Nobel has posted a 7 per cent rise in net income to €176 million for the first quarter of 2004, a little more than expected, but has warned that its pharmaceuticals division is in...
Ireland's Elan Corp has signed up another heavyweight partner - Switzerland's Roche - for its NanoCrystals technology, designed to improve the solubility of drug compounds.